Cabio Biotech Wuhan Co Ltd (688089) — Capital Reinvestment Ratio
Cabio Biotech Wuhan Co Ltd (688089) has a Capital Reinvestment Ratio of 0.97x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥56.10 Million) in capital expenditures (CN¥54.25 Million). Check Cabio Biotech Wuhan Co Ltd (688089) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Cabio Biotech Wuhan Co Ltd Capital Reinvestment Ratio (2013–2024)
This chart tracks Cabio Biotech Wuhan Co Ltd's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see Cabio Biotech Wuhan Co Ltd (688089) cash conversion ratio.
Annual Capital Reinvestment Ratio for Cabio Biotech Wuhan Co Ltd (2013–2024)
Year-by-year Capital Reinvestment Ratio for Cabio Biotech Wuhan Co Ltd from 2013 to 2024. See Cabio Biotech Wuhan Co Ltd (688089) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.22x | CN¥173.04 Million | CN¥211.60 Million | ▼ -71.7% |
| 2023 | 4.32x | CN¥68.89 Million | CN¥297.68 Million | ▲ +205.6% |
| 2022 | 1.41x | CN¥176.40 Million | CN¥249.47 Million | ▼ -15.8% |
| 2021 | 1.68x | CN¥103.29 Million | CN¥173.43 Million | ▲ +640.0% |
| 2020 | 0.23x | CN¥145.88 Million | CN¥33.10 Million | ▲ +28.6% |
| 2019 | 0.18x | CN¥131.95 Million | CN¥23.27 Million | ▲ +51.7% |
| 2018 | 0.12x | CN¥106.16 Million | CN¥12.34 Million | ▼ -49.5% |
| 2017 | 0.23x | CN¥100.66 Million | CN¥23.16 Million | ▼ -11.2% |
| 2016 | 0.26x | CN¥62.53 Million | CN¥16.21 Million | ▼ -46.6% |
| 2015 | 0.49x | CN¥44.58 Million | CN¥21.65 Million | ▲ +7.7% |
| 2014 | 0.45x | CN¥46.34 Million | CN¥20.90 Million | ▲ +11.1% |
| 2013 | 0.41x | CN¥39.48 Million | CN¥16.03 Million | — |